Daily non-political popular news in brief.

Long-term use of diabetes drug increases heart attack risk by more than 40 percent

An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues. There was no effect on death from cardiovascular causes.

Read more »

Keywords: long-term, diabetes, drug, heart, attack, risk, percent, long, term, diabete

« Previous | Next »

Similar news on "Long-term use of diabetes drug increases heart attack risk by more than 40 percent":

1. New strategy to cut heart attack risk is effective in initial test
   12-17-2007 · EurekAlert!
   The first clinical trial of a new kind of drug to cut the risk of cardiovascular disease has been found safe and effective at dropping levels of "bad" low density lipoprotein cholesterol by as much as 40 percent. High LDL levels increase the risk for heart attack and stroke.
   Similar news · Read more »
   
2. Debate Renewed: Diabetes drug ups heart risk
   09-15-2007 · Science News Online
   A popular diabetes drug significantly increases the risk of heart failure and heart attack in those who take it.
   Similar news · Read more »
   
3. New research shows ACTOS is associated with a 38 percent lower risk of heart attack
   09-19-2007 · EurekAlert!
   New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes, further support the cardiovascular safety of ACTOS (pioglitazone HCI) and its benefits regarding improved blood glucose and blood lipid levels for patients with type 2 diabetes.
   Similar news · Read more »
   
4. Diabetes drug might hike heart risk
   06-23-2007 · Science News Online
   People who take rosiglitazone, a popular diabetes drug marketed as Avandia, may face an increased risk of heart attack.
   Similar news · Read more »
   
5. Angioplasty reduces long-term cardiac risk among heart patients with 'silent' ischemia
   05-08-2007 · EurekAlert!
   When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack survivors with "silent ischemia," according to a study in the May 9 issue of JAMA.
   Similar news · Read more »
   
6. Older blacks and Latinos still lag whites in controlling diabetes
   09-24-2007 · EurekAlert!
   Despite decades of advances in diabetes care, African-Americans and Latinos are still far less likely than whites to have their blood sugar under control, even with the help of medications, a new national study finds. That puts them at a much higher risk of blindness, heart attack, kidney failure and other long-term diabetes complications. But the study also suggests opportunities to decrease the disparities.
   Similar news · Read more »
   
7. Metabolic syndrome affects nearly 1 in 10 US teens
   01-25-2008 · EurekAlert!
   About nine percent of teenagers may have metabolic syndrome, a clustering of risk factors that put them on the path toward heart disease and diabetes in adulthood. This shocking statistic represents some of the first concentrated efforts to define and measure metabolic syndrome in children and adolescents -- a necessary starting point for combating the problem, but one that has proven even trickier in youth than it has been in adults.
   Similar news · Read more »
   
8. Drug's potential adverse side effect explained
   09-06-2007 · EurekAlert!
   Drugs that are agonists of the receptor PPAR-gamma are used to treat individuals with diabetes. However, it has been suggested that their use is associated with a slightly increased risk of heart failure. A potential explanation for this adverse effect that is observed in a minority of patients is outlined in a new study in the Journal of Clinical Investigation.
   Similar news · Read more »
   
9. High-dose anticlotting drug cuts heart attack, death risk in half
   05-11-2007 · EurekAlert!
   Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.
   Similar news · Read more »
   
10. High-risk patients need better guidance on what is and isn't a heart attack
    07-05-2007 · EurekAlert!
    Varying advice means patients at high-risk of having a heart attack are unclear about when symptoms are potentially life threatening and when they should call an ambulance, argue a group of heart specialists in this week's BMJ.At least 70 percent of people who die from coronary heart disease have had previous heart problems.
    Similar news · Read more »